EMEA (Europe, Middle East and Africa) Nilotinib Market Report 2018

January 2018 | 102 pages | ID: E51B84F83FBEN
QYResearch

Abstracts

In this report, the EMEA Nilotinib market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Nilotinib for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Nilotinib market competition by top manufacturers/players, with Nilotinib sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Novartis

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• 50mg
• 200mg
• Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospital
• Drugs Store
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Nilotinib Market Report 2017

1 NILOTINIB OVERVIEW

1.1 Product Overview and Scope of Nilotinib
1.2 Classification of Nilotinib
  1.2.1 EMEA Nilotinib Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Nilotinib Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 50mg
  1.2.4 200mg
  1.2.5 Other
1.3 EMEA Nilotinib Market by Application/End Users
  1.3.1 EMEA Nilotinib Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Hospital
  1.3.3 Drugs Store
  1.3.4 Other
1.4 EMEA Nilotinib Market by Region
  1.4.1 EMEA Nilotinib Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Nilotinib (2012-2022)
  1.5.1 EMEA Nilotinib Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Nilotinib Revenue and Growth Rate (2012-2022)

2 EMEA NILOTINIB COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Nilotinib Market Competition by Players/Manufacturers
  2.1.1 EMEA Nilotinib Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Nilotinib Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Nilotinib Sale Price by Players (2012-2017)
2.2 EMEA Nilotinib (Volume and Value) by Type/Product Category
  2.2.1 EMEA Nilotinib Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Nilotinib Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Nilotinib Sale Price by Type (2012-2017)
2.3 EMEA Nilotinib (Volume) by Application
2.4 EMEA Nilotinib (Volume and Value) by Region
  2.4.1 EMEA Nilotinib Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Nilotinib Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Nilotinib Sales Price by Region (2012-2017)

3 EUROPE NILOTINIB (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Nilotinib Sales and Value (2012-2017)
  3.1.1 Europe Nilotinib Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Nilotinib Revenue and Growth Rate (2012-2017)
3.2 Europe Nilotinib Sales and Market Share by Type
3.3 Europe Nilotinib Sales and Market Share by Application
3.4 Europe Nilotinib Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Nilotinib Sales Volume by Countries (2012-2017)
  3.4.2 Europe Nilotinib Revenue by Countries (2012-2017)
  3.4.3 Germany Nilotinib Sales and Growth Rate (2012-2017)
  3.4.4 France Nilotinib Sales and Growth Rate (2012-2017)
  3.4.5 UK Nilotinib Sales and Growth Rate (2012-2017)
  3.4.6 Russia Nilotinib Sales and Growth Rate (2012-2017)
  3.4.7 Italy Nilotinib Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Nilotinib Sales and Growth Rate (2012-2017)

4 MIDDLE EAST NILOTINIB (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Nilotinib Sales and Value (2012-2017)
  4.1.1 Middle East Nilotinib Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Nilotinib Revenue and Growth Rate (2012-2017)
4.2 Middle East Nilotinib Sales and Market Share by Type
4.3 Middle East Nilotinib Sales and Market Share by Application
4.4 Middle East Nilotinib Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Nilotinib Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Nilotinib Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Nilotinib Sales and Growth Rate (2012-2017)
  4.4.4 Israel Nilotinib Sales and Growth Rate (2012-2017)
  4.4.5 UAE Nilotinib Sales and Growth Rate (2012-2017)
  4.4.6 Iran Nilotinib Sales and Growth Rate (2012-2017)

5 AFRICA NILOTINIB (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Nilotinib Sales and Value (2012-2017)
  5.1.1 Africa Nilotinib Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Nilotinib Revenue and Growth Rate (2012-2017)
5.2 Africa Nilotinib Sales and Market Share by Type
5.3 Africa Nilotinib Sales and Market Share by Application
5.4 Africa Nilotinib Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Nilotinib Sales Volume by Countries (2012-2017)
  5.4.2 Africa Nilotinib Revenue by Countries (2012-2017)
  5.4.3 South Africa Nilotinib Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Nilotinib Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Nilotinib Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Nilotinib Sales and Growth Rate (2012-2017)

6 EMEA NILOTINIB MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Novartis
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Nilotinib Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Novartis Nilotinib Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview

7 NILOTINIB MANUFACTURING COST ANALYSIS

7.1 Nilotinib Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Nilotinib

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Nilotinib Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Nilotinib Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA NILOTINIB MARKET FORECAST (2017-2022)

11.1 EMEA Nilotinib Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Nilotinib Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Nilotinib Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Nilotinib Price and Trend Forecast (2017-2022)
11.2 EMEA Nilotinib Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Nilotinib Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Nilotinib Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Nilotinib Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Nilotinib Sales Forecast by Type (2017-2022)
11.7 EMEA Nilotinib Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Nilotinib
Figure EMEA Nilotinib Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Nilotinib Sales Volume Market Share by Type (Product Category) in 2016
Figure 50mg Product Picture
Figure 200mg Product Picture
Figure Other Product Picture
Figure EMEA Nilotinib Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Nilotinib by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Drugs Store Examples
Table Key Downstream Customer in Drugs Store
Figure Other Examples
Table Key Downstream Customer in Other
Figure EMEA Nilotinib Market Size (Million USD) by Region (2012-2022)
Figure Europe Nilotinib Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Nilotinib Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Nilotinib Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Nilotinib Revenue (Million USD) Status and Forecast by Countries
Figure Africa Nilotinib Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Nilotinib Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Nilotinib Sales Volume and Growth Rate (2012-2022)
Figure EMEA Nilotinib Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Nilotinib Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Nilotinib Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Nilotinib Sales Share by Players (2012-2017)
Figure 2016 Nilotinib Sales Share by Players
Figure 2017 Nilotinib Sales Share by Players
Figure EMEA Nilotinib Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Nilotinib Revenue (Million USD) by Players (2012-2017)
Table EMEA Nilotinib Revenue Share by Players (2012-2017)
Table 2016 EMEA Nilotinib Revenue Share by Players
Table 2017 EMEA Nilotinib Revenue Share by Players
Table EMEA Nilotinib Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Nilotinib Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Nilotinib Sales Share by Type (2012-2017)
Figure Sales Market Share of Nilotinib by Type (2012-2017)
Figure EMEA Nilotinib Sales Market Share by Type (2012-2017)
Table EMEA Nilotinib Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Nilotinib Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Nilotinib by Type in 2016
Table EMEA Nilotinib Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Nilotinib Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Nilotinib Sales Share by Application (2012-2017)
Figure Sales Market Share of Nilotinib by Application (2012-2017)
Figure EMEA Nilotinib Sales Market Share by Application in 2016
Table EMEA Nilotinib Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Nilotinib Sales Share by Region (2012-2017)
Figure Sales Market Share of Nilotinib by Region (2012-2017)
Figure EMEA Nilotinib Sales Market Share in 2016
Table EMEA Nilotinib Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Nilotinib Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Nilotinib by Region (2012-2017)
Figure EMEA Nilotinib Revenue Market Share Regions in 2016
Table EMEA Nilotinib Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Nilotinib Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Nilotinib Revenue and Growth Rate (2012-2017)
Table Europe Nilotinib Sales (K Units) by Type (2012-2017)
Table Europe Nilotinib Market Share by Type (2012-2017)
Figure Europe Nilotinib Market Share by Type in 2016
Table Europe Nilotinib Sales (K Units) by Application (2012-2017)
Table Europe Nilotinib Market Share by Application (2012-2017)
Figure Europe Nilotinib Market Share by Application in 2016
Table Europe Nilotinib Sales (K Units) by Countries (2012-2017)
Table Europe Nilotinib Sales Market Share by Countries (2012-2017)
Figure Europe Nilotinib Sales Market Share by Countries (2012-2017)
Figure Europe Nilotinib Sales Market Share by Countries in 2016
Table Europe Nilotinib Revenue (Million USD) by Countries (2012-2017)
Table Europe Nilotinib Revenue Market Share by Countries (2012-2017)
Figure Europe Nilotinib Revenue Market Share by Countries (2012-2017)
Figure Europe Nilotinib Revenue Market Share by Countries in 2016
Figure Germany Nilotinib Sales (K Units) and Growth Rate (2012-2017)
Figure France Nilotinib Sales (K Units) and Growth Rate (2012-2017)
Figure UK Nilotinib Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Nilotinib Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Nilotinib Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Nilotinib Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Nilotinib Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Nilotinib Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Nilotinib Sales (K Units) by Type (2012-2017)
Table Middle East Nilotinib Market Share by Type (2012-2017)
Figure Middle East Nilotinib Market Share by Type (2012-2017)
Table Middle East Nilotinib Sales (K Units) by Applications (2012-2017)
Table Middle East Nilotinib Market Share by Applications (2012-2017)
Figure Middle East Nilotinib Sales Market Share by Application in 2016
Table Middle East Nilotinib Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Nilotinib Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Nilotinib Sales Volume Market Share by Countries in 2016
Table Middle East Nilotinib Revenue (Million USD) by Countries (2012-2017)
Table Middle East Nilotinib Revenue Market Share by Countries (2012-2017)
Figure Middle East Nilotinib Revenue Market Share by Countries (2012-2017)
Figure Middle East Nilotinib Revenue Market Share by Countries in 2016
Figure Saudi Arabia Nilotinib Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Nilotinib Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Nilotinib Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Nilotinib Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Nilotinib Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Nilotinib Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Nilotinib Sales (K Units) by Type (2012-2017)
Table Africa Nilotinib Sales Market Share by Type (2012-2017)
Figure Africa Nilotinib Sales Market Share by Type (2012-2017)
Figure Africa Nilotinib Sales Market Share by Type in 2016
Table Africa Nilotinib Sales (K Units) by Application (2012-2017)
Table Africa Nilotinib Sales Market Share by Application (2012-2017)
Figure Africa Nilotinib Sales Market Share by Application (2012-2017)
Table Africa Nilotinib Sales Volume (K Units) by Countries (2012-2017)
Table Africa Nilotinib Sales Market Share by Countries (2012-2017)
Figure Africa Nilotinib Sales Market Share by Countries (2012-2017)
Figure Africa Nilotinib Sales Market Share by Countries in 2016
Table Africa Nilotinib Revenue (Million USD) by Countries (2012-2017)
Table Africa Nilotinib Revenue Market Share by Countries (2012-2017)
Figure Africa Nilotinib Revenue Market Share by Countries (2012-2017)
Figure Africa Nilotinib Revenue Market Share by Countries in 2016
Figure South Africa Nilotinib Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Nilotinib Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Nilotinib Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Nilotinib Sales (K Units) and Growth Rate (2012-2017)
Table Novartis Nilotinib Basic Information List
Table Novartis Nilotinib Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis Nilotinib Sales (K Units) and Growth Rate (2012-2017)
Figure Novartis Nilotinib Sales Market Share in EMEA (2012-2017)
Figure Novartis Nilotinib Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Nilotinib
Figure Manufacturing Process Analysis of Nilotinib
Figure Nilotinib Industrial Chain Analysis
Table Raw Materials Sources of Nilotinib Major Manufacturers in 2016
Table Major Buyers of Nilotinib
Table Distributors/Traders List
Figure EMEA Nilotinib Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Nilotinib Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Nilotinib Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Nilotinib Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Nilotinib Sales Market Share Forecast by Region (2017-2022)
Table EMEA Nilotinib Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Nilotinib Revenue Market Share Forecast by Region (2017-2022)
Table Europe Nilotinib Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Nilotinib Sales Market Share Forecast by Countries (2017-2022)
Table Europe Nilotinib Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Nilotinib Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Nilotinib Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Nilotinib Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Nilotinib Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Nilotinib Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Nilotinib Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Nilotinib Sales Market Share Forecast by Countries (2017-2022)
Table Africa Nilotinib Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Nilotinib Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Nilotinib Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Nilotinib Sales Market Share Forecast by Type (2017-2022)
Table EMEA Nilotinib Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Nilotinib Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources